D&B Business Directory
Sandoz Inc.
Overview
Sandoz
Sandoz is the global leader in the biosimilars and generics markets, boasting one of the industry's broadest portfolios. Each year, it provides over 800 million patient treatments across more than 100 markets. Sandoz is well-positioned in both the biosimilars and generics sectors, offering a balanced risk profile and opportunities for significant growth and margin expansion in the midterm. The company has an attractive geographic footprint, being ...
Read More
a European champion with a presence in over 40 markets and holding a No. 1 or No. 2 position in most of the region's top markets. In the United States, Sandoz ranks as the fifth largest biosimilars and generics company, while in Canada, it holds the second position. Its International region also has a highly targeted global presence. Sandoz is particularly strong in the biosimilars segment, maintaining a leading position in key markets.
Read Less
Benhard Hamel   See more contacts
?
?
Actual

?
Actual
#
Modelled
?
Contacts
Get in Touch with 6 Principals* and 196 Contacts
  • Benhard Hamel
    President
  • Contact 2
    ?
  • Contact 3
    ?
  • Contact 4
    ?
D&B Hoovers Logo

Dynamic search and list-building capabilities

Real-time trigger alerts

Comprehensive company profiles

Valuable research and technology reports

Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Stay on top of your Business Credit File
Get full access to view your D&B business credit file now for just $39/month!
View D&B Scores & Ratings